Janice Caoili

Hub Lead, Executive Board Member

Dr Janice Caoili is a senior infectious diseases specialist, Chief of the Infectious Diseases Section at Department of Medicine, Makati Medical Center and a Research Consultant at the Tropical Disease Foundation. Her main interest focuses on TB, HIV, infection control, COVID-19 and emerging infections.

She has been engaged with research projects in South East Asia for over 15 years starting as coordinator for the US CDC Preserving Effective TB Treatment Study (PETTS) implemented in 9 countries including Thailand, Taiwan, South Korea and the Philippines and as the Deputy Program Manager for the HIV and AIDS Component, Global Fund to fight AIDS, Tuberculosis and Malaria (GFATM) Project.

She has collaborated with TB Alliance as the Principal Investifator (PI) for several Clinical Trials on novel anti TB drugs and new TB treatment regimen. These drugs are now part of drug resistant TB treatment regimens.

She is the PI of various clinical trials and projects at TDF and Makati Medical Center (MMC). She is the Co-investigator for MMC Site for the WHO Solidarity Trial for COVID-19 Treatment. This trial utilized an adaptive design and has enrolled 11,330 patients from 405 hospitals in 30 countries. The trial showed that some drugs used during the earlier part of the pandemic were not effective for COVID-19. Dr Caoili is one of the site leads for The WHO Solidarity Trial Vaccines that has enrolled almost 7,000 participants in the Philippines and still ongoing.

Dr Caoili is the Vice President and a Chair of the Philippine Society for Microbiology and Infectious Diseases (PSMID) and Board Member of the Philippine Coalition Against TB (PhilCAT) and involved in developing national guidelines and national strategy. She is also a member of the MMC Institutional Review Board involved in reviewing and monitoring of various research projects in the Philippines.